- Home
- SSP vs RGC Comparison
SSP vs RGC Comparison
Compare SSP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSP | RGC |
|---|---|---|
| Founded | 1878 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.2M | 9.8B |
| IPO Year | 1988 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SSP | RGC |
|---|---|---|
| Price | $4.07 | $25.25 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 260.9K |
| Earning Date | 11-06-2025 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,318,706,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.36 | $0.09 |
| 52 Week High | $4.98 | $83.60 |
Technical Indicators
Market Signals| Indicator | SSP | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 83.58 |
| Support Level | $4.27 | $16.30 |
| Resistance Level | $4.98 | $18.10 |
| Average True Range (ATR) | 0.36 | 2.14 |
| MACD | -0.12 | 0.96 |
| Stochastic Oscillator | 7.55 | 95.26 |
Price Performance
Historical ComparisonAbout SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.